ClinicalTrials.Veeva

Menu

Achieving Tuberculosis (TB) Control In Zambia

The University of Alabama at Birmingham logo

The University of Alabama at Birmingham

Status

Completed

Conditions

Tuberculosis

Treatments

Diagnostic Test: Screening at community level

Study type

Interventional

Funder types

Other

Identifiers

NCT03497195
IRB-300001132

Details and patient eligibility

About

To achieve TB control, innovative case finding interventions are needed that will reach the broader affected population including those that do not access the health facilities. Systematic community case finding with highly sensitive screening and diagnostic tools are needed. At the facility level, the index of suspicion for TB by health care workers needs to be raised to ensure that all those that need TB screening are appropriately screened.

Full description

The purpose of this study is to initiate sustained, active health facility and community-based case finding interventions to achieve improved TB case detection in high burden settings (Zambia) and contribute to TB control.

The interventions are expected to increase the impact of Xpert on TB case finding, thus increase TB case detection through scaling up of a combination of community level and facility level TB case finding interventions. The study will generate evidence on the added value of using Chest X-ray (CXR) screening at community level, whilst also comparing the performance of CXR with computer assisted diagnosis (CAD) and C-reactive protein (CRP) and symptoms as screening tools in terms sensitivity, specificity and cost effectiveness. Symptom screen alone has been shown to be suboptimal for screening as it misses a significant percentage of TB due to atypical presentation of TB in HIV-infected populations.

Enrollment

18,194 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

Program Implementation:

Inclusion criteria:

  • Any adult or child with TB symptoms (weight loss, chest pain, shortness of breath, fever, cough, hemoptysis, night sweats)
  • Ability to produce sputum
  • Verbal consent of parent or guardian if < 18 years old

Operations Research:

Inclusion criteria

  • Adults (18 years and older)
  • TB symptoms (weight loss, chest pain, shortness of breath, fever, cough, hemoptysis, night sweats)
  • Ability to provide a sputum sample
  • Willing to provide written informed consent
  • Willing to undergo full clinical evaluation
  • Willing to undergo a CXR

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Sequential Assignment

Masking

None (Open label)

18,194 participants in 2 patient groups

Community level screening; Arm 1
Active Comparator group
Description:
use of chest X-ray plus Xpert Ultra for community level TB screening
Treatment:
Diagnostic Test: Screening at community level
Community level screening: Arm 2
Active Comparator group
Description:
use of C-reactive Protein and Xpert Ultra for community level TB screening
Treatment:
Diagnostic Test: Screening at community level

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems